Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study

BMJ

Volumn 324, Issue 7334, 2002, Pages 393-396

  Taylor, Brent ^a   Miller, Elizabeth ^b   Lingam, Raghu ^a   Andrews, Nick ^b   Simmons, Andrea ^a   Stowe, Julia ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; CHILD; CHILDHOOD DISEASE; CONSTIPATION; DEVELOPMENTAL DISORDER; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; ENTEROPATHY; FOOD ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MEASLES VACCINATION; MENTAL DEFICIENCY; MUMPS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RUBELLA; SPEECH DISORDER; UNITED KINGDOM;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; HUMANS; INTESTINAL DISEASES; LOGISTIC MODELS; LONDON; MEASLES-MUMPS-RUBELLA VACCINE; MEDICAL RECORD LINKAGE; VACCINATION;

EID: 0037116793     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7334.393     Document Type: Article

References (14)

1. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637–641.
2. Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, et al. Autism and measles, mump and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026–2029.
3. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001; 19: 3632–3635.
4. Kaye JA, Melero-Montes M, Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001; 322: 460–463.
5. Dales L, Hammer S, Smith N. Time trends in autism and MMR immunisation in California. JAMA 2001; 285: 1183–1185.
6. DeWilde S, Carey IM, Richards S, Hilton SR, Cook DG. Do children who become autistic consult more often after MMR vaccination? Brit J Gen Pract 2001; 51: 226–227.
7. Wakefield AJ. Testimony to the Congress of the United States House of Representatives Committee on Government Reform: hearing on the challenges of autism. Why the increased rates? A one year update. Washington. April 2001. http://www.house.gov/reform/hearings/healthcare/01.04.25/wakefield.htm. [accessed 7 February 2002]
8. Kurita H, Kita M, Miyaka A. A comparative study of development and symptoms among disintegrative psychosis and infantile autism with and without speech loss. J Autism Dev Disord 1992; 22: 175–188.
9. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001; 108: e58.
10. Wakefield A, Anthony A, Murch S, Thomson M, Montgomery SM, Davies S, et al. Enterocolitis and immunodeficiency in children with developmental disorders. Am J Gastroenterol 2000; 95: 2285–2295.
11. Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, et al. Colonic CD8 and γd T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001; 138: 366–372.
12. Gershon M. Testimony to the Congress of the United States House of Representatives Committee on Government Reform: hearing on the challenges of autism. Why the increased rates? A one year update. Washington. April 2001. http://www.house.gov/reform/hearings/healthcare/01.04.25/gershon.htm. [accessed 8 February 2002]
13. Halsey NA, Hyman SL. Conference writing panel. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the new challenges in childhood immunizations conference convened in Oak Brook, Illinois, Jun 12–13, 2000. Pediatrics 2001; 107(5):1–23. http://www.pediatrics.org/cgi/content/full/107/5/e84.
14. Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659–685.